EU official: AstraZeneca pulls out of vaccine delivery talks
And EU official says AstraZeneca has pulled out of meeting with the European Union to discuss delayed vaccine commitments to the bloc
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.AstraZeneca has pulled out of meeting with the European Union to discuss delayed vaccine commitments to the bloc, an EU official said.
The official, who asked not to be identified because of the sensitivity of the talks, said the EU would “insist on them” coming back to the negotiating table to explain the delay in deliveries once the Oxford-AstraZeneca vaccine gets approved for use by the European Medicines Agency. The EU's drug regulator was scheduled to hold on meeting on approving the vaccine on Friday.
Wednesday’s talks with the EU Commission and member states were slated to be the third in as many days, as an ever angrier EU is demanding an explanation about the delays.
AstraZeneca said in a statement that they “understand and share in the frustration that initial supply volumes of our vaccine delivered to the European Union will be lower than forecast."
It did not address the issue of the planned meeting with the EU's steering board, which brings together experts from the executive Commission, the member states, and in this case, hopefully AstraZeneca.
On Monday, the EU threatened to impose tight export controls within days on COVID-19 vaccines made in the bloc.
The EU, which has 450 million citizens and the economic and political clout of the world's biggest trading bloc, is lagging badly behind countries like Israel and Britain in rolling out coronavirus vaccine shots for its health care workers and most vulnerable people. That's despite having over 400,000 confirmed virus deaths since the pandemic began.
The shortfall of planned deliveries of the AstraZeneca vaccine combined with hiccups in the distribution of Pfizer-BioNTech shots as that company upgrades production facilities at a plant in Belgium is putting EU nations under heavy political pressure.
___
Follow all of AP’s pandemic coverage at:
https://apnews.com/hub/coronavirus-pandemic
https://apnews.com/hub/coronavirus-vaccine
https://apnews.com/UnderstandingtheOutbreak